Market Cap (In INR)
5.56 Billion
Revenue (In INR)
1.82 Billion
Net Income (In INR)
3.19 Million
Avg. Volume
191.61 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 100.2-214.95
- PE
- -
- EPS
- -
- Beta Value
- 0.0
- ISIN
- -
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Santosh Shantilal Vora
- Employee Count
- -
- Website
- https://valiantlabs.in
- Ipo Date
- 2023-10-06
- Details
- Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also offers specialty chemicals. The company was formerly known as Bharat Chemicals and changed its name to Valiant Laboratories Limited in August 2021. The company was founded in 1980 and is based in Mumbai, India. Valiant Laboratories Limited is a subsidiary of Dhanvallabh Ventures LLP.
More Stocks
-
FENC
-
CCNTFConcentric AB (publ)
CCNTF
-
601699
-
NEA
-
176ARezil Inc.
176A
-
IVXInvion Limited
IVX
-
BRYBri-Chem Corp.
BRY
-
TSLTessellis S.p.A.
TSL